New combo may beat standard treatment for parasitic disease
NCT ID NCT04410406
First seen Feb 01, 2026 · Last updated May 24, 2026 · Updated 13 times
Summary
This study tested whether a drug called moxidectin works better than the standard ivermectin for clearing the parasite that causes lymphatic filariasis (a disease that can lead to severe swelling). 164 adults with the infection received one of four single-dose drug combinations. Researchers tracked how many people had no parasites in their blood 12 and 24 months later. The goal is to find a more effective treatment to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHATIC FILARIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Regional Hospital of Agboville, Southern Cote d'Ivoire
Agboville, Côte d’Ivoire
Conditions
Explore the condition pages connected to this study.